Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis

Table 2

Main characteristics of all studies included in the meta-analysis for EGFR.

References	Year	Origin	Case-controls	Antibody source	Dilution	Cut-off value
Rakha et al. [1]	2007	UK	249/1293	Novocastra	1 : 10	>10%
Gasparini et al. [10]	2014	USA	381/262	Dako	1 : 100	>10%
Tang et al. [14]	2012	China	40/158	Dako	Not available	>0%
Koo and Jung [24]	2011	Korea	8/109	Novocastra	1 : 50	>10%
Nogi et al. [33]	2009	Japan	26/85	Novocastra	Not available	>0%
Nozoe et al. [34]	2011	Japan	7/30	Dako	1 : 10	>10%
Pillai et al. [35]	2012	Malaysia	18/18	Dako	1 : 50	>1%
Rydén et al. [36]	2010	Sweden	87/299	Dako	Prediluted	>1%
Tan et al. [37]	2008	UK	31/209	Zymed	1 : 50	Not available
Tawfik et al. [38]	2010	USA	151/379	Zymed	1 : 20	Not available